Combining clinical and epidemiologic features for early recognition of SARS.
Early recognition and rapid initiation of infection control precautions are currently the most important strategies for controlling severe acute respiratory syndrome (SARS). No rapid diagnostic tests currently exist that can rule out SARS among patients with febrile respiratory illnesses. Clinical features alone cannot with certainty distinguish SARS from other respiratory illnesses rapidly enough to inform early management decisions. A balanced approach to screening that allows early recognition of SARS without unnecessary isolation of patients with other respiratory illnesses will require clinicians not only to look for suggestive clinical features but also to routinely seek epidemiologic clues suggestive of SARS coronavirus exposure. Key epidemiologic risk factors include 1) exposure to settings where SARS activity is suspected or documented, or 2) in the absence of such exposure, epidemiologic linkage to other persons with pneumonia (i.e., pneumonia clusters), or 3) exposure to healthcare settings. When combined with clinical findings, these epidemiologic features provide a possible strategic framework for early recognition of SARS.
Jernigan
John A
JA
Intervention and Evaluation Section, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. jjernigan@cdc.gov
Low
Donald E
DE
Hefland
Rita F
RF
D016000:Cluster Analysis; D003142:Communication; D003937:Diagnosis, Differential; D004196:Disease Outbreaks; D015981:Epidemiologic Factors; D006801:Humans; D012141:Respiratory Tract Infections / Q000175:diagnosis; D012307:Risk Factors; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis* / Q000453:epidemiology* / Q000635:transmission